Dicerna Pharmaceuticals CEO Douglas Fambrough's 2018 pay jumps 102% to $2.5M
Dicerna Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Dicerna Pharmaceuticals reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, four executives at Dicerna Pharmaceuticals received on average a compensation package of $1.5M, a 56% increase compared to previous year.
Average pay of disclosed executives at Dicerna Pharmaceuticals
Douglas M. Fambrough, III, Chief Executive Officer, received $2.5M in total, which increased by 102% compared to 2017. 66% of Fambrough's compensation, or $1.6M, was in option awards. Fambrough also received $335K in non-equity incentive plan, $507K in salary, as well as $19K in other compensation.
Bob D. Brown, Chief Scientific Officer, received a compensation package of $1.3M, which increased by 78% compared to previous year. 52% of the compensation package, or $674K, was in option awards.
John B. Green, Chief Financial Officer, earned $1.3M in 2018.
Ralf Rosskamp, Chief Medical Officer, received $1M in 2018, which increases by 8% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 26, 2019.